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Abstract
Background: The papillary cystic and solid tumour of the pancreas (PCSTP) is a rare primary
neoplasm of unknown pathogenesis typically found in young women. PCSTP is a low-grade
malignant tumour, which is often asymptomatic but it may present with abdominal pain.
Case presentation: A 38 year old female patient who presented with one day history of
epigastric pain was diagnosed as PCSTP. The patient was successfully treated with distal
pancreatectomy.
Conclusion: It is important to differentiate this tumour from other pancreatic tumours because,
unlike malignant pancreatic tumours, this neoplasm does not usually metastasise and is amenable
to cure after complete surgical resection. However, the cell origin and the aetiology of this tumour
are not clear and further studies are warranted in its pathogenesis.
Background
The Papillary cystic and solid tumour of the pancreas
(PCSTP) is an unusual low-malignant epithelial tumour,
which mostly affects young females with a mean age 25
years [1-3]. Nearly 90–95% of the patients are female [2-
4]. It has also been referred to as a solid-cystic epithelial
tumour, solid-pseudopapillary tumour or papillary-cystic
tumour [5]. It makes up 0.2–2.7% of all pancreatic can-
cers [6,7]. Since the original description by Frantz in 1959
the incidence of PCSTP has been increasing [8], although
it may be that it is increasingly being diagnosed. Further-
more, some authors believe that the tumour is not rare but
occasionally is misdiagnosed as carcinoma [1]. we report
here a case andpresent the literature review.
Case presentation
A 38-year-old female presented with a one day history of
acute epigastric pain. There was no nausea or vomiting.
She had developed non-Insulin dependant diabetes 18
months previously. On examination she was overweight
and there was epigastric tenderness, but no mass was pal-
pable. All haematological and biochemical parameters
were within normal limits.
Abdominal ultrasonography demonstrated a 5 × 3 cm par-
tially cystic mass in distal pancreas with a possibility of a
cystic neoplasm. A contrast enhanced computed tomogra-
phy (CT) scan confirmed a 2 cm mass in the body of pan-
creas (Figure 1). Dynamic contrast enhanced magnetic
resonance imaging (MRI) showed a 4 cm cystic lesion in
the body of Pancreas suggestive of a mucinous cyst
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adenocarcinoma (Figure 2). No liver or abdominal metas-
tases were detected on either the ultrasound or CT
examination.
The patient underwent staging laparoscopy which showed
no metastases. Laparotomy was performed. An en-block
distal pancreatectomy, including the pancreatic mass, and
splenectomy was performed with full clearance of peri-
pancreatic and coeliac nodes. The patient made an une-
ventful recovery.
On gross examination the pancreatic tumour was oval, 7.0
cm in diameter, and was surrounded by a fibrous pseudo-
capsule. Its cut surface showed solid and cystic spaces (Fig-
ure 3). On microscopy, the solid portion of the tumour
revealed sheets of uniform polygonal cells as well as dys-
cohesive papillae arranged around fine fibrovascular
cores. The cyst wall was composed of dense acellular
fibrous tissue within which the tumour cells were
arranged as cords and trabeculae set within a mucinous
background (Figure 4).
No invasion of the tumour into surrounding normal tis-
sue was present. The tumour cells were strongly positive
for vimentin and alpha-1 antitrypsin and showed faint
focal positivity with MNF116 and chromogranin.
Discussion
The presenting features of PCSTP are relatively non-spe-
cific. In the case of large tumours, patients present with
symptoms related to compression of adjacent structures.
The tumours are either found incidentally or they gener-
ally cause mild abdominal symptoms such as abdominal
discomfort or chronic and acute pain. Jaundice is rare,
CT scan showing lesion in the pancreas Figure 1
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even in tumours that originate from the head of the pan-
creas and usually there is no associated functional
endocrine syndrome [9-12]. Rarely, these tumours are
found due to haemoperitoneum from rupture of the
tumour [3,13]. Physical examination might show a palpa-
ble mass and epigastric tenderness [3].
PCSTP usually arises in the tail, the body, or occasionally
in the head of the pancreas. The body and the tail of the
pancreas are most frequently affected [3,4]. PCSTP may
appear to be extra-pancreatic with only localised connec-
tion to the gland [9]. Development of the tumour in
ectopic sites of pancreatic tissue has also been described
[1].
Laboratory investigations provide little additional infor-
mation [14]. Elevated serum tumour markers (CEA,
CA19-9) have not been described with PCSTP [8,15].
Ultrasonographic findings are not characteristic and they
may be suggestive of papillary tumour [16]. In PCSTP,
ultrasonography reveals a sharply demarcated, well cir-
cumscribed, variably solid and cystic mass without any
internal septation [3,17]. CT scaning presents a variable
picture depending on the relationship of cystic-necrotic to
solid components. Typically, on CT scan PCSTP tumours
appear as sharply circumscribed, well-encapsulated, heter-
ogeneous and hypodense lesions [4,12].
Koito et al [18], reported that endoscopic ultrasonography
may provide an accurate diagnosis of pancreatic cystic
MRI showing cystic and solid lesion in the pancreas Figure 2
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tumours<2 cm. Additional studies are warranted in this
area [19].
MRI offers good visualization of haemorrhagic areas [20].
On MRI, PCSTPs are sharply demarcated and have areas of
high signal intensity corresponding to foci of haemor-
rhage [9].
The origin and histogenesis of this tumour is controversial
[3,21] and little is known about it [22]. The fact that
PCSTP tumours may express epithelial as well as mesen-
chymal markers and occasionally show exocrine and
endocrine features suggesting an origin from a stem cell.
However, the nature of the tumour cells is not obvious
from their structure and behaviour. In addition, their
strongly sex-linked occurrence is not in keeping with an
origin from a stem cell. In one case, the tumour cells were
highly reactive to progesterone antibody, while they were
negative for estrogen. These findings suggest a ductal ori-
gin for PCSTP, and also suggested that the sex hormones
play a role in its growth, but not its genesis [23].
The neoplasm is generally encapsulated and is well
demarcated from the remaining pancreas[15]. The cut sur-
face reveals lobulated, light brown solid areas admixed
with zone of haemorrhage and necrosis as well as cystic
spaces filled with necrotic debris[22].
PCSTP has mixed histological features including: solid
monomorphous pattern with variable sclerosis, a pseudo-
papillary, trabecular and microcystic patterns [24].
Although criteria of malignancy have not been clearly
established [15], unequivocal perineural invasion or
angioinvasion, with or without deep invasion into the
surrounding tissue, is taken to indicate malignant behav-
iour [11,22]. The most useful markers are alpha-1-antit-
rypsin, alpha-1-antichymotrypsin, neuron spesific
enolase (NSE) and Vimentin [22,25].
Gross specimen of the lesion Figure 3
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One study found a definite increase in both oestrogen and
progesterone receptors in the PCSTP tumour relative to
both presently determined and previously published lev-
els in normal pancreas. The very high levels of
progesterone receptor detected in this tumour support the
hypothesis that the PCSTP is oestrogen-responsive, since
expression of progesterone receptor is induced by oestro-
gen, and thus constitutes an index of effective oestrogen
action in a given tissue [26]. Oestrogen and progesterone
receptors have been demonstrated by biochemical assays
in four solid-pseudopapillary tumour [11,26]. Immuno-
histologically, some studies fail to detect nuclear oestro-
gen receptors [11,25] while progesterone receptors had
been demonstrated in eight tumours [11].
Although a few case reports suggested that the preopera-
tive diagnosis of PCSTP is possible by using fine needle
aspiration (FNA), especially in clinically typical examples
[9,20,22]. FNA was avoided in many cases because of the
potential risk of tumour spillage and this may compro-
mise surgical cure [1,27]. However, cytology obtained via
FNA may not be useful to differentiate between pancrea-
toblastoma and PCST and if the tumour is operable, FNA
is not necessary.
The differential diagnosis of PCSTP includes any cystic
and/or solid pancreatic process such as: congenital pan-
creatic cysts, haemorrhagic pseudocyst, parasitic hydatid
cyst, and other common cystic neoplasms of the pancreas,
such as serous cystadenoma or cystadenocarcinoma,
mucinous cystic neoplasms, cystic islet cell tumours,
pancreatoblastoma, or mucinous duct ectasia [2,4,19].
Cases of PCSTP can mimic pancreatic cyst, occasionally
mistakenly treated by cystogastrotomy [27].
Photomicrograph of papillary cystic and solid tumour of the pancreas (haematoxylin and eosin ×40) Figure 4
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Complete resection is the treatment of choice [14], and
the standard therapy should involve complete removal of
the tumour, the associated lymph nodes, the involved
pancreas and any adjacent involved organs. Local inva-
sion, recurrence, or limited metastases should not be con-
sidered contraindications to resection [1,27]. Surgery
should be performed even if local infiltration is present,
and in selected cases when complete excision is not possi-
ble, excision combined with postoperative radiotherapy
to the residual mass has been used. [3]
Surgical management has been tailored to the slow-grow-
ing, non-invasive nature of this tumour. Depending on
the location of the PCSTP, the surgical operation is cho-
sen. With tumour involvement of the head of pancreas, a
pylorus-preserving pancreaticoduodenectomy is recom-
mended [27]. PCSTPs involving the neck or body of the
pancreas were resected by central pancreatectomy and
reimplantation of the pancreatic remnant into the stom-
ach, with theoretical benefit of preserving pancreatic
parenchyma and spleen [27]. When the tumour was
located at the pancreatic tail, tail and body, or body of
pancreas, distal pancreatectomy with splenectomy was
employed in many cases [3]. Many authors recommended
splenic conservation following distal pancreatectomy
when possible [1,27].
Given the low grade malignancy and the excellent progno-
sis of PCSTP, conservative resection such as enucleation,
evolution, lumpectomy, central pancreatectomy and par-
tial resection of the head of pancreas have been suggested
as safe and effective surgical procedures, especially in pae-
diatric patients [3,5,16,28,29].
However, if at all possible, complete and radical excision
should be the aim, as surgical curability is high and there
is no clearly established role for radio-chemotherapy or
embolisation in the treatment of PCSTP [20]. However,
sporadic reports are present. Matusuda et al, reported a
case of multiple hepatic metastases which responded to
chemo-embolisation of the tumour [1], Fried et al,
observed substantial shrinkage of an unresctable tumour
after 6 weeks of radiotherapy [1].
PCSTP is a remarkably indolent neoplasm, and is
regarded as a carcinoma of low malignant potential [9].
Most authors consider PCSTP as a benign or low-grade
malignancy [20]. More than 95% of patients with PCSTP
limited to the pancreas are cured by complete surgical
excision. Clear resection margins are necessary to prevent
local recurrence [9]. Surprisingly, even patients with met-
astatic disease have experienced long-term survival[9].
Conclusion
PCSTP is uncommon primary pancreatic neoplasm of
unknown aetiology with low malignant potential gener-
ally occurring in young women. The sex and age distribu-
tion suggests that hormonal factors may be important in
the pathogenesis of PCSTP. PCSTP should be considered
in the differential diagnosis of any pancreatic mass, espe-
cially in young women. Unlike other pancreatic malig-
nant tumours, this neoplasm is indolent and metastases
are rare. The treatment of choice is complete surgical
removal and the prognosis is excellent after complete sur-
gical resection.
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